// App-Quantinova.ai

Mo1757 : CENTRALLY-DETERMINED STANDARDIZATION OF FLOW CYTOMETRY METHODS REDUCES INTER-LABORATORY VARIATION IN A PROSPECTIVE MULTICENTER STUDY

Researchers

Presenter

  • Tanja van Viegen

Principal Investigators

  • Dermot McGovern

  • Julian Panes

  • Azucena Salas

  • William J. Sandborn

  • Mark S. Silverberg

  • Michelle I. Smith

  • Severine Vermeire

  • Stefania Vetrano

  • Lisa Shackelton

  • Larry Stitt

  • Azar Azad

  • Vipul Jairath

  • Barrett Levesque

  • David Spencer

  • Brian G. Feagan

  • Niels Vande Casteele

  • Janine Bilsborough

  • Gijs van den Brink

  • Silvio Danese

  • Geert R. -Haens

  • Lars Eckmann

  • William Faubion

  • Hannelie Korf

Medical Centers

  • Humanitas University, Rozzano, Italy

  • University of Western Ontario, London, ON, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

  • Mayo Clinic Rochester, Rochester, Minnesota, United States

  • University of California San Diego, CA, United States

  • Hospital Clinic Barcelona, Barcelona, Spain

  • University of Leuven, KUL, Leuven, Belgium

  • Academic Medical Center, Amsterdam, Netherlands

  • Tytgat Institute for Liver and Intestinal Research, Amsterdam, Netherlands

  • Los Angeles, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Los Angeles, United States

Locations

  • Canada

  • Italy

  • Netherlands

  • Spain

  • United States

  • Belgium

Companies

  • Robarts Clinical Tri

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Interleukin 17A

Drug/Treatment

  • lonomycin

Outcome

  • Unknown

Study Design

  • pharmacodynamics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved